Início › Câncer de Ovário › Flórida › Jacksonville
Ensaios clínicos de Câncer de Ovário em Jacksonville, FL
16 estudos para Câncer de Ovário estão buscando participantes em locais em Jacksonville e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Mayo Clinic in Florida, Jacksonville
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RecrutandoFase 2
- Mayo Clinic in Florida, Jacksonville
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecrutandoEstudo observacional
- Mayo Clinic, Jacksonville
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecrutandoFase 1
- Research Site, Jacksonville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecrutandoEstudo observacional
- Mayo Clinic Jacksonville, Jacksonville
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecrutandoFase 3
- Baptist MD Anderson Cancer Center, Jacksonville
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
RecrutandoFase 2
- Mayo Clinic Jacksonville, Jacksonville
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
RecrutandoFase 4
- University of Florida Jacksonville, Jacksonville
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Mayo Clinic (Florida), Jacksonville
- Cancer Specialists of North Florida, Jacksonville
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
RecrutandoFase 3
- Mayo Clinic Florida, Jacksonville
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecrutandoFase 1/2
- Mayo Clinic - Jacksonville, Jacksonville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Mayo Clinic, Jacksonville
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecrutandoFase 1/2
- Mayo Clinic, Jacksonville
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecrutandoFase 2
- Mayo Clinic Florida, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Jacksonville
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #15, Jacksonville
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
Outros estudos em Jacksonville
- Câncer de Mama40 estudos
- Câncer de Pulmão de Não Pequenas Células39 estudos
- Câncer (todos os tipos)29 estudos
- Câncer Metastático28 estudos
- Câncer Colorretal27 estudos
- Câncer de Próstata26 estudos
- Obesidade25 estudos
- Insuficiência Cardíaca21 estudos
- Câncer de Pâncreas20 estudos
- Sobrepeso19 estudos
- Mieloma Múltiplo18 estudos
- Câncer de Pulmão17 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.